Status:
COMPLETED
Clinical Reminders in Test Reports to Improve Guideline Compliance
Lead Sponsor:
US Department of Veterans Affairs
Conditions:
Heart Failure, Congestive
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Although beta-blockers are known to prolong survival for patients with reduced left ventricular ejection fraction, their use in the community and the VA is suboptimal.
Detailed Description
Background: Although beta-blockers are known to prolong survival for patients with reduced left ventricular ejection fraction, their use in the community and the VA is suboptimal. Objectives: To de...
Eligibility Criteria
Inclusion
- Those undergoing echocardiography at one of the participating laboratories with an ejection fraction \< 45%.
Exclusion
- aortic stenosis, mitral stenosis
Key Trial Info
Start Date :
May 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2006
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT00414401
Start Date
May 1 2001
End Date
June 1 2006
Last Update
April 7 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Palo Alto Health Care System, Palo Alto, CA
Palo Alto, California, United States, 94304-1290